Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol

British Journal of Clinical Pharmacology
P J PhillipsB M Duncan

Abstract

The metabolic and cardiovascular side-effects of intravenous infusions of therapeutic doses of beta 2-adrenoceptor agonists salbutamol and rimiterol have been determined in four healthy male subjects. There were dose-related increases in plasma glucose, renin activity, serum insulin and heart rate, and significant hyperlactataemia and ketonaemia. There were dose-related decreases in plasma potassium, phosphate and corticosteroids and significant hypocalcaemia and hypomagnesaemia. The effects of equivalent molar amounts of salbutamol and rimiterol were similar. Whichever drug is used, special care is required with patients who may have abnormal glucose tolerance, potassium depletion, or be predisposed to lactic acidosis. Rimiterol may be preferable for infusion because of its short plasma half-life.

References

Aug 1, 1975·Metabolism: Clinical and Experimental·J L Day
Aug 13, 1977·British Medical Journal·D J ThomasW A Stubbs
Sep 17, 1977·British Medical Journal·D Leslie, P M Coats
Oct 29, 1977·British Medical Journal·D Leopold, A McEvoy
Oct 1, 1977·Thorax·S Williams, A Seaton
Mar 5, 1977·British Medical Journal·M G Chapman
Apr 2, 1977·British Medical Journal·J M Steel, J Parboosingh
Apr 30, 1977·British Medical Journal·C J Chandler
May 1, 1977·British Journal of Obstetrics and Gynaecology·S K Smith, D Thompson
Jul 1, 1977·British Journal of Obstetrics and Gynaecology·D J ThomasK G Alberti
Sep 17, 1977·British Medical Journal·T C Smith
Jan 1, 1976·Current Medical Research and Opinion·R Lindsay
Feb 1, 1975·Postgraduate Medical Journal·R GoldbergH C Seftel
Jun 1, 1975·British Journal of Obstetrics and Gynaecology·D G McDevittC R Whitfield
Dec 13, 1975·British Medical Journal·R W PainB M Duncan
Feb 1, 1973·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M E EvansJ W Paterson
Oct 1, 1973·Acta Endocrinologica·Y NakaiS Matsukura
Jan 1, 1968·Annual Review of Biochemistry·G A RobisonE W Sutherland
Mar 1, 1972·Clinica Chimica Acta; International Journal of Clinical Chemistry·A ChandrasekaranP S Lord
Jun 1, 1971·The American Journal of Physiology·E P Todd, R L Vick
Oct 1, 1973·The Journal of Clinical Investigation·J A FischerU Binswanger
Jul 27, 1974·British Medical Journal·K H Ng, D K Sen
Apr 1, 1971·European Journal of Pharmacology·L E MartinC Harrison
Jun 1, 1967·American Heart Journal·B Surawicz
Aug 1, 1970·The American Journal of Physiology·A J Vander
Jun 1, 1968·The Journal of Clinical Investigation·W G Blackard, S A Heidingsfelder

❮ Previous
Next ❯

Citations

Jan 1, 1989·European Journal of Clinical Pharmacology·N A MintonJ A Henry
Jan 1, 1989·European Journal of Clinical Pharmacology·M Edner, T Jogestrand
Jan 1, 1982·Pharmacology & Therapeutics·A E Tattersfield
Jan 1, 1990·Pharmacology & Therapeutics·T H Pringle, J G Riddell
Jul 23, 1983·Lancet·S R Smith, M J Kendall
Mar 22, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Antony E TobinJohn D Santamaria
Jan 1, 2010·BMJ Case Reports·R Saxena, G Marais
Oct 1, 1988·The American Review of Respiratory Disease·A S VathenenA E Tattersfield
Nov 27, 2010·Annales Françaises D'anesthèsie Et De Rèanimation·N FritschB Fontaine
Oct 25, 2014·Annals of the American Thoracic Society·Hilary M DuBrock, Peter F Clardy
Jun 15, 2007·Anaesthesia·R Jee, H Brownlow
Jun 1, 1982·Journal of Clinical and Hospital Pharmacy·M J KendallS Westerling
Mar 1, 1982·Journal of Clinical and Hospital Pharmacy·M J KendallD J Worthington
Jun 1, 1987·Journal of Clinical Pharmacy and Therapeutics·S R Smith
Apr 28, 2017·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Eike BlohmMark Neavyn
Sep 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·N E MadiasS Herson
Mar 12, 2010·Human & Experimental Toxicology·K OwenS J P Damment
Jul 29, 2003·Anesthesiology·Edwin B LiemMichael E Mahla
Jul 14, 2010·Fundamental & Clinical Pharmacology·Torben Clausen
Mar 20, 2004·Journal of Cardiovascular Electrophysiology·Per InsulanderHans Vallin
Aug 27, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jacob Atsmon, Eran Dolev
Jan 15, 2015·Archives of Disease in Childhood. Education and Practice Edition·Matthew NeameIan Sinha
Jan 22, 2020·Drug Testing and Analysis·Morten HostrupAnders Krogh Lemminger
Dec 23, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jang-Hyuk YunChung-Hyun Cho
Oct 5, 2018·The Journal of Clinical Endocrinology and Metabolism·Johan OnslevMorten Hostrup
Jan 1, 1987·British Journal of Clinical Pharmacology·K F WhyteJ L Reid
Nov 1, 1987·British Journal of Clinical Pharmacology·P M McCaffreyR G Shanks
Apr 1, 1986·British Journal of Clinical Pharmacology·S R Smith, M J Kendall
Jan 2, 2020·Journal of Clinical Medicine·Alina G LiedtkePietro B Faré
May 1, 1994·The Annals of Pharmacotherapy·G R Brown, J K Greenwood
Jul 5, 2011·CJEM·Reid McGonigle, Robert A Woods
Jun 1, 1992·Journal of Clinical Pharmacy and Therapeutics·C A Haffner, M J Kendall
Feb 10, 2016·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Tony ZitekDavid E Slattery

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.